Literature DB >> 11276042

The Reed-Sternberg cell in classical Hodgkin's disease.

W C Chan1.   

Abstract

There has been substantial advances in our understanding of the nature of the Hodgkin/Reed-Sternberg (H/RS) cell in recent years. There is now compelling evidence that the H/RS cells in the vast majority of cases of classical Hodgkin's disease (CHD) are derived from the B-cell lineage and a major clonal population is present. The immunoglobulin heavy chain variable region gene generally has a high load of somatic mutations suggesting that the H/RS cells are derived from germinal center (GC) (GC) or post-GC cells. The cellular milieu in the tumour is largely determined by the cytokines and chemokines secreted by the H/RS cells and the surrounding reactive elements. The pattern of secretion is partially determined by signals transduced through direct surface interactions between H/RS cells and infiltrating T-cells. Immunosuppressive cytokines and cytokines that preferentially induce a TH2 type of immune response may be partially responsible for the escape of the H/RS cells from immune surveillance. Multiple genes that have been shown to be involved in neoplastic transformation have been studied in HD. The significance of the data generated has been difficult to interpret. Efforts have been made to study the global gene expression pattern of the H/RS cells. There are many difficulties inherent in this approach, but new insight into the pathogenesis and evolution of HD would be expected from the studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276042     DOI: 10.1002/hon.659

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  5 in total

1.  Non-AIDS-Defining Malignancies in the HIV-Infected Population.

Authors:  Chia-Ching J Wang; Michael J Silverberg; Donald I Abrams
Journal:  Curr Infect Dis Rep       Date:  2014-06       Impact factor: 3.725

2.  Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

Authors:  Robert J Biggar; Elaine S Jaffe; James J Goedert; Anil Chaturvedi; Ruth Pfeiffer; Eric A Engels
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

3.  Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.

Authors:  Jessica A Shafer; Conrad R Cruz; Ann M Leen; Stephanie Ku; An Lu; Alexandra Rousseau; Helen E Heslop; Cliona M Rooney; Catherine M Bollard; Aaron E Foster
Journal:  Leuk Lymphoma       Date:  2010-05

Review 4.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

5.  Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.

Authors:  Nizar M Mhaidat; Osama Y Alshogran; Omar F Khabour; Karem H Alzoubi; Ismail I Matalka; William J Haddadin; Ibraheem O Mahasneh; Ahmad N Aldaher
Journal:  J Exp Clin Cancer Res       Date:  2011-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.